Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC).
Luke R G PikeEmily MiaoLillian A BoeTejas PatilBrandon S ImberNathaniel J MyallErqi L PollomCaressa HuiVera QuJacob LangstonVeronica L ChiangMichael GrantSarah B GoldbergJoshua David PalmerRahul N PrasadTony J C WangAlbert LeeCatherine A ShuLanyi Nora ChenNicholas J ThomasSteve E BraunsteinBrian D KavanaghD Ross CamidgeChad G RusthovenPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
and ALK-driven NSCLC. Patients with larger BM (≥1 cm) may benefit the most from up-front SRS.